| Breakdown | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 1.84B | 1.78B | 1.71B | 1.70B | 1.87B |
| Gross Profit | 383.85M | 366.81M | 350.56M | 358.23M | 431.86M |
| EBITDA | 205.59M | 168.86M | 161.95M | 161.72M | 209.85M |
| Net Income | 98.19M | 88.90M | 80.05M | 76.91M | 106.28M |
Balance Sheet | |||||
| Total Assets | 2.02B | 1.94B | 2.07B | 1.96B | 2.19B |
| Cash, Cash Equivalents and Short-Term Investments | 631.59M | 545.16M | 534.54M | 453.73M | 450.54M |
| Total Debt | 47.31M | 52.87M | 61.26M | 61.34M | 68.78M |
| Total Liabilities | 839.95M | 842.33M | 1.03B | 970.19M | 1.20B |
| Stockholders Equity | 1.12B | 1.04B | 970.33M | 916.59M | 899.25M |
Cash Flow | |||||
| Free Cash Flow | 115.22M | 34.81M | 96.86M | 63.45M | -14.94M |
| Operating Cash Flow | 136.72M | 58.77M | 124.08M | 83.53M | 33.83M |
| Investing Cash Flow | -13.36M | -7.76M | -311.00K | -68.46M | -42.24M |
| Financing Cash Flow | -38.72M | -36.96M | -40.14M | -4.76M | -51.16M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
79 Outperform | HK$734.91M | 3.05 | 8.89% | 6.25% | 3.66% | 10.37% | |
76 Outperform | HK$482.81M | 3.98 | 11.59% | ― | 1.82% | -2.78% | |
65 Neutral | $2.17B | 12.19 | 3.79% | 4.94% | 3.15% | 1.96% | |
62 Neutral | HK$569.75M | 27.88 | 1.30% | 7.09% | 4.53% | 247.06% | |
61 Neutral | HK$712.84M | -7.59 | -2.25% | 3.33% | -22.33% | -82.88% | |
49 Neutral | HK$700.00M | -24.81 | -4.93% | 4.14% | -3.01% | -178.00% | |
45 Neutral | HK$449.92M | -0.31 | -107.79% | 7.31% | -4.07% | -4882.20% |